RT Journal Article
T1 Guidelines for living donor kidney transplantation
A1 Frutos, Miguel Angel
A1 Crespo, Marta
A1 de la Oliva Valentin, Maria
A1 Alonso-Melgar, Angel
A1 Alonso, Juana
A1 Fernandez, Constantino
A1 Garcia-Erauzkin, Gorka
A1 Gonzalez, Esther
A1 Gonzalez-Rinne, Ana M.
A1 Guirado, Lluis
A1 Gutierrez-Dalmau, Alex
A1 Huguet, Jorge
A1 Lopez del Moral, Jose Luis
A1 Musquera, Mireia
A1 Paredes, David
A1 Redondo, Dolores
A1 Revuelta, Ignacio
A1 Van-der Hofstadt, Carlos J.
A1 Alcaraz, Antonio
A1 Alonso-Hernandez, Angel
A1 Alonso, Manuel
A1 Bernabeu, Purificacion
A1 Bernal, Gabriel
A1 Breda, Alberto
A1 Cabello, Mercedes
A1 Luis Caro-Oleas, Jose
A1 Cid, Joan
A1 Diekmann, Fritz
A1 Espinosa, Laura
A1 Facundo, Carme
A1 Garcia, Marta
A1 Gil-Vernet, Salvador
A1 Lozano, Miquel
A1 Mahillo, Beatriz
A1 Jose Martinez, Maria
A1 Miranda, Blanca
A1 Oppenheimer, Federico
A1 Palou, Eduard
A1 Jose Perez-Saez, Maria
A1 Peri, Lluis
A1 Rodriguez, Oscar
A1 Santiago, Carlos
A1 Tabernero, Guadalupe
A1 Hernandez, Domingo
A1 Dominguez-Gil, Beatriz
A1 Pascual, Julio
K1 Glomerular-filtration-rate
K1 Stage renal-disease
K1 Rabbit antithymocyte globulin
K1 Antibody-mediated rejection
K1 Antigen-specific immunoadsorption
K1 Coated mycophenolate sodium
K1 Positive cross-match
K1 Term-follow-up
K1 Antilymphocyte induction therapy
K1 Intravenous immune globulin
AB This guide for living donor renal transplantation (LDRT) has been prepared with the sponsorship of the Spanish Society of Nephrology (SEN), the Spanish Transplant Society (SET), and the Spanish National Transplant Organization (ONT). It updates evidence to offer the best chronic renal failure treatment when a potential living donor is available. The core aim of this guide is to supply clinicians who evaluate living donors and transplant recipients with the best decision-making tools, to optimise their outcomes.Moreover, the role of living donors in the current RT context should recover the level of importance it had until recently. To this end the new forms of incompatible HLA and/or ABO donation, as well as the paired donation which is possible in several hospitals with experience in LDRT, offer additional ways to treat renal patients with an incompatible donor. Good results in terms of patient and graft survival have expanded the range of circumstances under which living renal donors are accepted. Older donors are now accepted, as are others with factors that affect the decision, such as a borderline clinical history or alterations, which when evaluated may lead to an additional number of transplantations.This guide does not forget that LDRT may lead to risk for the donor. Pre-donation evaluation has to centre on the problems which may arise over the short or long-term, and these have to be described to the potential donor so that they are able to take them into account. Experience over recent years has led to progress in risk analysis, to protect donors' health. This aspect always has to be taken into account by LDRT programmes when evaluating potential donors.Finally, this guide has been designed to aid decision-making, with recommendations and suggestions when uncertainties arise in pre-donation studies. Its overarching aim is to ensure that informed consent is based on high quality studies and information supplied to donors and recipients, offering the strongest possible guarantees. (C) 2021 Published by Elsevier Espana, S.L.U. on behalf of Sociedad Espanola de Nefrologia.
PB Soc espanola nefrologia dr rafael matesanz
SN 0211-6995
YR 2022
FD 2022-04-11
LK http://hdl.handle.net/10668/22418
UL http://hdl.handle.net/10668/22418
LA es
DS RISalud
RD Mar 14, 2025